Loading
A phase 2 trial of durvalumab, monalizumab and oleclumab in lung cancer, run by Montefiore Medical Center, not yet recruiting.
The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2 is a phase 2, randomised interventional study registered as NCT07146230 by Montefiore Medical Center, with a registry enrolment figure of 52 participants, started 2026-09 and due to reach its primary completion in 2028-04. Interventions recorded: Durvalumab; Monalizumab; Oleclumab; Radiotherapy. Conditions listed: Non-small Cell Lung Cancer. Primary outcome: Response rate observed using FDG-PET imaging. Lung eligibility wording from the registry: "Previously untreated, pathologically proven NSCLC and one of the following stages:". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Unresectable stage III non-small-cell lung cancer, Durvalumab, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), AstraZeneca, IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), AstraZeneca, IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Monalizumab, Durvalumab, Lung cancer trials open today (registry snapshot), AstraZeneca and the tag lung-deep-dive.
Shares Durvalumab, Lung cancer trials open today (registry snapshot), AstraZeneca, IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Durvalumab, Lung cancer trials open today (registry snapshot), AstraZeneca and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.